secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cytek Biosciences, Inc. (CTKB)
CIK:        0001831915
Form:       8-K
Filed at:   2026-07-15T20:15:11+00:00
Accession:  0001193125-26-304789
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Cytek Biosciences enters severance and consulting agreements with former CLO Valerie Barnett
--------------------------------------------------------------------------------

- Valerie Barnett's CLO role terminated June 29, 2026; severance lump sum of $365,775.12 plus COBRA through April 30, 2027.
- If change in control occurs within 3 months, enhanced severance: 18 months base salary plus 2026 bonus target, COBRA through Jan 31, 2028, and equity acceleration.
- Consulting agreement from July 10 to Aug 31, 2026 at $1,000/hour, max 10 hours/week, with continued equity vesting during term.
- Previously granted equity awards under 2021 Equity Incentive Plan continue to vest subject to Continuous Service during consulting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831915/000119312526304789/0001193125-26-304789-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831915/000119312526304789/d99130d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-304789

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer